Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juliette Soret

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Blood Cancer Journal|July 15, 2021
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospitalNicolas Vallet, Sylvie Chevret, Linda Feghoul, et al.
Leukemia|December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratificationHélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.
Nature Communications|July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsNabih Maslah, Nina Kaci, Blandine Roux, et al.
Leukemia|October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter studyYu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.
Blood|January 25, 2020
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuriaAlexander Röth, Jun-Ichi Nishimura, Zsolt Nagy, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Leukemia|December 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasmsAlexandre Guy, Olivier Mansier, Matisse Decilap, et al.
American Journal of Hematology|February 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHMLaura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood Cancer Journal|July 15, 2021
Characteristics and mid-term follow-up of COVID-19 patients with hematological diseases: a retrospective study from a French tertiary care hospitalNicolas Vallet, Sylvie Chevret, Linda Feghoul, et al.
Leukemia|December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratificationHélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.
Nature Communications|July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsNabih Maslah, Nina Kaci, Blandine Roux, et al.
Leukemia|October 4, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter studyYu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin, et al.
Blood|January 25, 2020
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuriaAlexander Röth, Jun-Ichi Nishimura, Zsolt Nagy, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Leukemia|June 18, 2025
A molecular signature predicts hematologic evolution in polycythemia vera patientsOlivier Mansier, Eric Lippert, Lina Benajiba, et al.
Leukemia|December 23, 2025
Thromboinflammation is associated with high thrombotic risk in patients with newly diagnosed myeloproliferative neoplasmsAlexandre Guy, Olivier Mansier, Matisse Decilap, et al.
American Journal of Hematology|February 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHMLaura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, et al.
Pageof 3